Interestingly, when a DC-vaccine was used to immunize against the single antigenic Id protein, FL patients with relapsed or residual diseases after induction therapy developed anti-Id T-cell and Ab responses associated with durable tumor regressions, in particular when Id was conjugated with KLH (59). This evidence concerns the gene ID1 and neoplasm.